A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

NCT02704702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Fimasartan
DRUG: Rosuvastatin
DRUG: Fimasartan + Rosuvastatin

Sponsor

Boryung Pharmaceutical Co., Ltd